Skip to main content

Question for Department of Health and Social Care

UIN 271414, tabled on 1 July 2019

To ask the Secretary of State for Health and Social Care, what steps he is taking to regulate the cannabidiol market; and whether he plans to create a new medical model for the (a) tetrahydrocannabinol and (b) cannabidiol sectors.

Answered on

4 July 2019

Given that cannabidiol extracts are found in many products and not just in food, Departmental officials are also working with other Government departments to assess all the relevant issues. We will consider evidence to develop the most suitable approach for regulation and compliance. The Food Standards Agency (FSA) will continue to engage with stakeholders on how the Government can achieve this.

On 1 November 2018, the Government changed the law to enable specialist doctors to prescribe cannabis-based products for medicinal use. This includes products containing tetrahydrocannabinol and cannabidiol. The regulations use the existing regulatory frameworks for medicines and the misuse of controlled drugs, an approach which the Government believes is proportionate and evidence-based, ensuring that clinicians can access these products whilst minimising the risk of misuse, harm and diversion.

The Food Standards Agency (FSA) has been working with local authorities, businesses, consumers and other stakeholders to determine how to regulate the cannabidiol market and achieve compliance in a proportionate manner.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.